• Careers
  • Locations
  • Investors
  • Investigators
  • Study Volunteers
  • Blog
  • Login
  • Japan Site
  • About
    • People. Purpose. Passion.
    • Overview
      • Our Mission
      • Making the Complex Seamless
      • Full-Service CRO
      • Trusted by Biotech
    • Ethics and Compliance
    • Global Reach
    • Leadership
    • Locations
    • Careers
      • Transform Your Career
      • Why Work at Medpace?
      • Where We Are
      • What We Do
      • Career Testimonials
  • Solutions
    • Overview
    • Early Phase Clinical Research
      • Capabilities
      • Phase I Unit
    • Phase II-III Clinical Research
    • RWE – Late Phase Clinical Research
      • Capabilities
      • Observational Research
      • Health Economics and Outcomes Research
      • Technology for Real World Evidence
        and Late Phase Research
    • Medical Device and Diagnostics
      • Capabilities
      • Global Partner
      • Clinical and Regulatory Services for Medical Devices
      • Specialties
  • Capabilities
    • Overview
    • Biostatistics and Data Sciences
    • Clinical Monitoring
      • Capabilities
      • CRA Training Program
    • Clinical Trial Management
      • Capabilities
      • Study Start-Up
      • Enhancing Patient Diversity in Clinical Trials
      • Patient Recruitment
      • Decentralized Clinical Trials
    • Drug Safety and Pharmacovigilance
    • Medical Department
      • Overview
      • Advanced Clinical Practitioners
    • Quality Assurance
    • Regulatory Affairs
      • Overview
      • Services
    • Risk-Based Monitoring
  • Labs
    • Overview
    • Virtual Laboratory Tours
    • Central Laboratories
      • Overview
      • Capabilities
      • Biomarkers
      • Safety Testing
      • Featured Methods
      • Highlighted Therapeutic Expertise
      • Biorepository Services
      • Accreditations
      • Test Directory
    • Bioanalytical Laboratories
      • Capabilities
      • Assays and Scientific Posters
      • Request for Information – Bioanalytical Assays
    • Imaging & ECG Core Labs
      • Capabilities
      • Cardiovascular Imaging
      • Dermatologic Imaging
      • DXA Imaging Services
      • ECG Services
      • Image Quantification Services (IQS)
      • Metabolic Imaging
        • Metabolic Imaging
        • NASH/NAFLD Imaging
      • Neurology Imaging
      • Nuclear Imaging & Radiopharmaceuticals
      • Oncology Imaging
      • Wearable Biosensor Technology
  • Therapeutic Specialties
    • Overview
    • Autoimmune Diseases
    • Cardiovascular
    • Dermatology
    • Endocrine & Metabolic
    • Gastroenterology
    • Hematology & Oncology
      • Overview
      • Immuno-Oncology
    • ID & Vaccines
    • NASH & Liver Disease
    • Nephrology & Renal Disease
    • Neuroscience
      • Overview
      • Neurodegenerative Diseases
      • Neuromuscular Diseases
      • Pain-Related Clinical Development
      • Psychiatry
      • Substance Use Disorders
      • Stroke
    • Ophthalmology
    • Pediatrics
    • Rare Diseases
    • Cellular & Gene Therapy
      • Overview
      • Cell Tracking
    • Radiation Therapy
  • Technology
    • Overview
    • Clinical Trial Management
    • Interactive Response Technology (IRT)
    • Laboratory Information Management
    • Electronic Data Capture (EDC)
    • Imaging
    • ePRO/eCOA/eDiary
    • Wearable Biosensor Technology
  • Resources
    • Overview
    • Blog
    • Newsletter
  • Contact

Emerging Biotechs: The Trailblazers of Drug Development

Emerging biotechs are a force to be reckoned with. In 2018, approximately 70% of clinical pipelines belonged to emerging biotechs, who were also responsible for nearly 64% of new active substances approved by the FDA. In other words, 38 out of 59 approved therapies were patented by emerging biotechs last year. These numbers prove that biotechs are leveling the playing field and are leading innovation in the drug discovery and development space.

As this space becomes increasingly crowded, companies will need to develop and differentiate their portfolio to be the real winners. Biotechs are confronted with various challenges, especially in the early, high-risk stages of compound development.

Challenges for Emerging Biotechs: What’s Keeping You Up at Night?

Rising drug development costs, a steadily accelerating race to collect impactful data, increasing knowledge of the epidemiology of diseases, growing competition for suitable trial sites, and a generally crowded market, are all factors that shape the highly competitive landscape of the life sciences industry.

“Biotech companies are working to develop treatments that haven’t been defined, with science that has yet to be tested, to treat diseases that we are only now beginning to understand. Working with these innovators and pioneers makes our work at Medpace incredibly exciting and fulfilling as we help to advance these novel medical therapies.”

Reinilde Heyrman, MD, Vice President of the Medical Department at Medpace  

As a CRO dedicated to the support of emerging biotechs, Medpace takes pride in our clients’ work. As a partner, we share your passion for research and strive to help you achieve success.

Medpace and Biotechs

Labiotech, a leading digital media covering the European Biotech industry recently featured Medpace in their white paper, “A Toolkit for Emerging Biotechs: Practical Advice for Navigating Challenges and Advancing Clinical Development”  Download the white paper now to learn more about about the challenges biotechs face with solutions to dominate and lead innovation in the industry.

Bonus Download: Winning at your Drug Development Strategy: A playbook for emerging biotechs

Download the White Paper

Learn more about the challenges biotechs face during early-stage drug development and the solutions that will allow emerging biotechs to continue to lead innovation.

Plus get bonus whitepaper

Winning at Your Drug Development Strategy: A playbook for emerging biotechs

  • Our Locations
  • Careers
  • Labs
  • Capabilities
  • Technology
  • Resources
  • Investors
  • Investigators
  • Study Volunteers
  • Blog
  • About
  • Mission
  • Ethics and Compliance
  • Global Reach
  • Leadership
  • Locations
  • Careers
  • Solutions
  • Early Phase Clinical Research
  • Phase II-III Clinical Research
  • RWE - Late Phase Clinical Research
  • Medical Device and Diagnostics
  • Therapeutic Specialities
  • Autoimmune Diseases
  • Cardiovascular
  • Endocrine & Metabolic
  • Gastroenterology
  • Hematology & Oncology
  • Infectious Diseases & Vaccines
  • NAFLD/NASH
  • Nephrology & Renal
  • Neuroscience
  • Ophthalmology
  • Pediatrics
  • Cellular & Gene Therapy
  • Rare Disease & Orphan Indications
  • Radiation Therapy

Contact

Medpace, Inc.
5375 Medpace Way
Cincinnati, Ohio 45227 USA
Toll-free: +1.800.730.5779
Tel: +1.513.579.9911
Fax: +1.513.579.0444

© 2023 Medpace, All Rights Reserved | Privacy Policy | Accessibility Statement | UK Modern Slavery Act | Terms of Use | Sitemap

Important Cookie Information – This message will only appear once.
Medpace websites use cookies. By continuing to browse the site you are agreeing to our use of cookies.
For more details about cookies and their use, please see our Privacy Policy.